Optimus too could launch Covid pill Paxlovid soon


Optimus too could launch Covid pill Paxlovid soonAfter Hetero Labs, Hyderabad-based Optimus Pharma has got close to launching in the country the generic version of Pfizer‘s antiviral drug Paxlovid, which is being touted as a game changer in the fight against Covid-19.

The company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator this week for a review, said people aware of the matter.

“We have completed our studies and will submit the data this week,” a company executive told ET on condition of anonymity, adding that the studies show that the drug “works well”. Once it gets the approval, the company will be able to introduce the medicine within a month. Optimus Pharma has the capacity to produce 50 million tablets per month.

In January, the subject expert committee (SEC) under the drug regulator had asked both Hetero Labs and Optimus Pharma to conduct BA/BE studies and submit safety data.

Last week, the drug regulator approved Paxlovid for restricted emergency use against Covid-19 amid another increase in infections in the country. Hetero Labsis working on the price of the pill and is likely to launch the drug this week.

“The stiff competition among the firms will ensure that the costs are affordable for patients,” said another person, who did not wish to be identified. The drug is available by prescription only and should be taken as soon as possible after the diagnosis of Covid-19 and within five days of symptom onset. Pfizer had last year announced a deal with MPP, a United Nations-backed body, to issue royalty-free voluntary licences to manufacture generic versions of Paxlovid in 95 middle-income and low-income countries, including India.

MPP last month announced a tie-up with 35 firms, including 19 drugmakers from India, to produce the generic version of Paxlovid.


Health & Wellness News Source link

Procommun Suggestions

Leave a Reply

Your email address will not be published.

Related Posts